RAND Corporation and the Moran Company issued reports discussing the cost savings associated with biosimilars.
The event will take place on November 21 in Basel.
In Cameroon, seeking treatment for chronic diseases can be a long journey.
Cameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable medicines and educating patients.
Novartis reaches agreement with Uganda to supply medicines that address the rapid rise of chronic diseases in the country. Uganda becomes the fifth country to launch Novartis Access.
Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.
Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.